San Jose, California, Yuni 29, 2021 (Kamfanin Labarai na Duniya) -BGI Gene Americas, jagora na duniya a gwajin gwaji, a yau ya sanar da haɗin gwiwa tare da kamfanin Advaite na ilimin halittu na Pennsylvania da ƙaddamar da dxpartnerships.com, Cibiyar don kamfanonin bincike. neman haɗin gwiwa ta hanyar lasisi, masana'antun kayan aiki na asali (OEM) ko yarjejeniyar rarraba.
Haɗin gwiwar zai ƙara Advaite's RapCov™ Rapid COVID-19 Gwajin zuwa babban fayil ɗin BGI na hanyoyin gwajin gwaji.Gwajin Advaite shine rigakafi na CLIA wanda ba a keɓance shi ba don gano ingantattun ƙwayoyin rigakafi na immunoglobulin G (IgG) akan kwayar cutar SARS-CoV-2 a cikin samfuran jini gaba ɗaya daga yatsun ɗan adam.Gwajin saurin RapCov™ na COVID-19 shine ɗayan farkon gwaje-gwajen serological na farko da Amurka ta yi wanda Hukumar Abinci da Magunguna ta Amurka ta ba da izinin amfani da gaggawa.Yana da sauƙi don amfani kuma yana ba da sakamako mai kyau a cikin minti 15, yana kawar da buƙatar aika samfurori.Bukatun zuwa dakin gwaje-gwaje.Wannan haɗin gwiwar yana ba BGI damar haɗa gwajin mallakar mallakar Advaite tare da kayan aikin sa na ainihin lokaci na RT-PCR don gano SARS-CoV-2, yana ba da dakin gwaje-gwaje na tsakiya da CLIA na kulawa don tsarin asibiti da sauran cibiyoyin kiwon lafiya mafita na gwaji.
Shugaban Advaite Karthik Musunuri ya ce: "Kayan gwajin rigakafinmu na gaggawa yana ba da mafita mai kyau don tantance adadin mutane kuma yana taimaka wa marasa lafiya sanin ko sun taɓa kamuwa da wannan cutar ba tare da saninsu ba."Haɗin gwiwar BGI don samarwa asibitoci da sauran cibiyoyin kiwon lafiya sabbin gwaje-gwajenmu yana da sauƙi wajen taimakawa yaƙi da wannan annoba da ke ci gaba.”
Cutar sankarau ta COVID-19 ta ba da haske game da buƙatun duniya don samarwa da rarraba kayan gwaji masu isa da ingantattun kayan gwaji.Ƙaddamar da BGI na dxpartnerships.com yana bawa kamfani damar yin haɗin gwiwa tare da ƙungiyoyi masu yawa a fagen gwajin gwaji don ci gaba da magance cutar.Tare da ƙwararrun ƙwararrun kasuwanci da manyan sawun duniya, aiki tare da BGI yana ba ƙungiyoyin damar yin kasuwanci da sauri da kuma yadda ya kamata su tallata hanyoyin binciken su na in vitro.
Craig Hoechstetter, BGI's ya ce "A matsayin daya daga cikin manyan masu samar da kayan aikin ganowa na COVID-19 da tsarin sarrafa kansa, muna farin cikin yin aiki tare da Advaite don kawo mafita na gano majagaba a kasuwa da kuma taimakawa dakatar da yaduwar cutar sankara mai kisa," in ji Craig Hoechstetter, BGI's. ci gaban kamfanoni.“Gwaji cikin sauri da sauƙi ba wai kawai tunatar da mutane ko sun kamu da cutar ba, har ma ya ba su damar samun magani cikin sauri da ɗaukar matakan da suka dace don rage yaduwar cutar ga abokan aiki, abokai da danginsu, da kuma ceton rayuka.Ta hanyar samar da ƙarshen-zuwa-ƙarshe Tare da ingantattun ingantattun ƙwayoyin cuta da gwajin ƙwayar cuta, muna samar da mafita ta haɗin gwiwa don amsa wannan annoba ta kasancewa mataki ɗaya a gaban kwayar cutar. "
Don yin aiki tare da BGI, da fatan za a ziyarci dxpartnerships.com.Don ƙarin bayani kan gwajin BGI da RapCov™ mai saurin COVID-19, da fatan za a ziyarci bgi.com/us.
Kamfanin BGI Americas shine babban mai ba da sabis na ilimin genomics da proteomics a cikin Amurka, wanda ke da alaƙa da BGI Genomics, kamfani da aka jera akan Kasuwancin Hannun jari na Shenzhen.An kafa shi a cikin 2010, BGI Americas ya haɓaka har ya haɗa da kasuwanci a Boston da San Jose, yana ba da sabis ga abokan ciniki da yawa a fagen binciken binciken kwayoyin halitta, haɓaka magunguna, da bincike.Dangane da cutar ta COVID-19 ta 2020, BGI America ta gabatar da hanyoyin bincikenta ga kasuwannin Arewacin Amurka da Kudancin Amurka tare da ƙaddamar da kasuwancin binciken in vitro.BGI yana kawo shekaru 20 na ƙwarewar genomics ga abokan cinikinta da masu haɗin gwiwa.Mun himmatu wajen inganta binciken kwayoyin halitta, fasaha da aikace-aikace don amfanin bil'adama.
ADVAITE Inc. kamfani ne na fasahar kere-kere da ke da hedikwata a Malvern, Pennsylvania, yana mai da hankali kan haɓaka sabbin jiyya da bincike don taimakawa marasa lafiya da ke fama da cututtuka daban-daban.Kalmar “Advaite” tana nufin “ba komai”, mara misaltuwa ko na musamman.A ADVAITE, ƙungiyarmu tana ɗokin yin hakan.
A halin yanzu, ADVAITE Inc. yana mai da hankali kan haɓaka sabbin hanyoyin ganowa nan take don taimakawa yaƙi da COVID-19, cuta mafi muni a duniyar zamani.ADVAITE yana da babban dakin gwaje-gwaje na CLIA a Chicago, Illinois, da kuma fa'idodin R&D na zamani a Malvern, Pennsylvania.ADVAITE yana ci gaba da ƙirƙira, haɓakawa da kasuwanci gwajin gwajin kulawa na aji na farko don amsa wannan annoba da taimakawa Tasirin adadi mai yawa na mutane.
Gwajin saurin ADVAITE RapCov ™ COVID-19 gwaji ne na immunochromatographic na gefe don gano ingantattun ƙwayoyin rigakafi na IgG a kan SARS-CoV-2 a cikin samfuran jini gaba ɗaya daga yatsun ɗan adam.Gwajin gwajin tsintsiya gabaɗayan samfuran jini yana iyakance ga dakunan gwaje-gwajen da aka amince da CLIA waɗanda suka cika buƙatun don yin babban, matsakaita, ko keɓantaccen gwaji.An ba da izinin yin amfani da gwajin tsintsiya ga duka samfuran jini a cikin POC, wato, a cikin yanayin kula da majiyyaci wanda ke aiki daidai da takaddun keɓewar CLIA, takaddun yarda, ko takaddun shaida.A halin yanzu, ba a bayyana tsawon lokacin da kwayoyin rigakafin za su dade ba bayan kamuwa da cuta, da kuma ko kasancewar kwayoyin cutar zai haifar da rigakafi.
Lokacin aikawa: Jul-01-2021